(1 year ago)
Commons ChamberI apologise to right hon. and hon. Members for any confusion that my movements around the Chamber may have created earlier, Mr Deputy Speaker.
New clause 45 is about the comparability and interoperability of health data across the UK. I say to the hon. Member for Rhondda (Sir Chris Bryant), the Opposition spokesman, that I have never been called pregnant before—that is a new description—but I will return to his point shortly in these brief remarks. There are three important reasons worth stating why data comparability is important. The first is that it empowers patients. The publication of standardised outcomes gives patients the ability to make informed choices about their treatment and where they may choose to live. Secondly, it strengthens care through better professional decision making. It allows administrators to manage resources and scientists to make interpretations of the data they receive. Thirdly, comparable data strengthens devolution, administration and policy making in the health sector. Transparent and comparable data is essential for that and ensures that we, as politicians, are accountable to voters for the quality of services in our area.
We could have an academic and philosophical discussion about this, but what brings me to table new clause 45 is the state of healthcare in north Wales. We have a health board that has been in special measures for the best part of eight years, and I have to wonder if that would be the case if the scrutiny of it were greater. One of the intentions of devolution was to foster best practice, but in order for that to happen we need comparability, which has not proved to be the case in the health sector.
For example, NHS Scotland does not publish standard referral to treatment times. Where it does, it does not provide averages and percentiles, but rather the proportion of cases meeting Scotland-only targets. In Wales, RTTs are broadly defined as the time spent waiting between a referral for a procedure and getting that procedure. In England, only consultant-led pathways are reported, but in Wales some non-consultant-led pathways are included, such as direct access diagnostics and allied health professional therapies, such as physiotherapy and osteopathy, which inevitably impact waiting times.
On cancer waiting times, England and Scotland have a target of a test within six weeks. However, there are different numbers of tests—eight north and 15 south of the border—and different measures for when the period ends—until the last test is completed in England or until the report is written up in Scotland. Those who understand health matters will make better sense of what those differences mean, but I simply make the observation that there are differences.
In Wales, the way we deal with cancer waiting times is different. Wales starts its 62-day treatment target from the date the first suspicion is raised by any health provider, whereas in England the 62-day target is from the date a specialist receives an urgent GP referral. Furthermore, in Wales routine referrals reprioritised as “urgent, with suspicion of cancer” are considered to be starting a new clock.
What can be done about this and why does it require legislation? New clause 45 may seem familiar to hon. Members because it was first brought forward as an amendment to the Health and Care Bill in 2022. It was withdrawn with the specific intention of giving the Government the time to develop a collaborative framework for sharing data with the devolved Administrations. I pay tribute to all four Governments, the Office for National Statistics and officials for their work since then.
Notwithstanding that work, on 5 September 2023 Professor Ian Diamond, the UK national statistician, made the following remarks to the Public Administration and Constitutional Affairs Committee about gathering comparative health data across the devolved Administrations:
“You are entirely right that statistics is a devolved responsibility and therefore the data that are collected for administrative purposes in different parts of the United Kingdom differ. We have found it very difficult recently to collect comparable data for different administrations across the UK on the health service, for example.”
On working more closely with the devolved Administrations’ own statistical authorities, he said:
“We have been working very hard to try to get comparable data. Comparable data are possible in some areas but not in others. Trying to get cancer outcomes—”
as I have just referred to—
“is very difficult because they are collected in different ways… While statistics is devolved, I do not have the ability to ensure that all data are collected in a way that is comparable. We work really hard to make comparable data as best as possible, but at the moment I have to be honest that not all data can be compared.”
Mr Deputy Speaker, new clause 45 was brought forward as a constructive proposal. I believe that it is good for the patients, good for the professionals who work on their healthcare, and good for our own accountability. I do not think that this House would be divided on grounds of compassion or common sense. I thank all those Members who have supported my new clause and urge the Government to legislate on this matter. Today was an opportunity for me to discuss the issues involved, but I shall not be moving my new clause.
With the leave of the House, I call the Minister to wind up the debate.
(1 year, 11 months ago)
Commons ChamberI acknowledge the hard-working staff of Betsi Cadwaladr University Health Board, who serve us to the best of their ability and make terrific efforts to give us the care that we need and deserve in north Wales.
I want to mention Welsh colleagues from across the House, many of whom share my concern over the state of the health service in Wales. I know that some who are not present today will share that concern, even on the Opposition Benches, although it does raise the question of why they are not present. My right hon. Friend the Member for Vale of Glamorgan (Alun Cairns) and my hon. Friend the Member for Clwyd South (Simon Baynes) make the case for Wales as a case study of healthcare under Labour. I add to their observations that healthcare spending now accounts for some 55% of the Welsh Government budget.
I want to look briefly at the effects of the Labour prescription for healthcare in Wales. Our treatable mortality rate is 20% higher than in England. Last year, five out of seven of our health boards were in some form of special measures. My health board, the Betsi Cadwaladr University Health Board, was in special measures for six years. It got so bad that the BBC reported on a patient from Swansea who was forced to go to Lithuania for a hip operation when she discovered that she was on year four of a seven-year waiting list for treatment. The hon. Member for Batley and Spen (Kim Leadbeater), who is not in her place, was absolutely correct when she said that the Government have to take responsibility—the Welsh Government must take responsibility for their 25 years of stewardship of healthcare in Wales.
On the defence of the hon. Member for Ilford North (Wes Streeting) for the inequalities in Wales, I would say this: in 2015, the Nuffield Trust reported that the Welsh Government had used their powers to set different priorities and a different tone from their London counterpart. It has emphasised prevention—
(2 years ago)
Commons ChamberI thank you for your patience, Robin Millar.
I welcome the Secretary of State’s statement. It sets out a compelling narrative of, on the one hand, Russian terror, overreach and folly, on the other hand, the bravery of the Ukrainian troops and the resilience of the Ukrainian people. I know that many people in Aberconwy will welcome the role that the Government have played in supporting Ukraine and the role of our British troops. Can he offer assurances that UK armed forces will remain in Ukraine, not least in support of our diplomatic presence in the country?
(2 years, 5 months ago)
Commons ChamberI am grateful to the hon. Gentleman, but I think the rather more dangerous point, which has already been made tonight, relates to the damage that this will do to our reputation for integrity and the position that we will find ourselves in when we criticise President Putin for breaking international law, which of course he does over and over again.
Does my right hon. Friend really think that that is a fair comparison to make?
I gently suggest to my young friend that, if I had not thought it was a fair comparison, I would not have made it.
I feel very strongly that we are going down an extremely dangerous path. I believe passionately in the Belfast/Good Friday agreement, and we have to get back on track, but we are not going to make Maroš Šefčovič’s job any easier by lumbering him with this legislation. I am sure that it will ultimately get through this House—whether it gets through the other place is another matter—but I hope very much indeed that an agreement can be reached before it becomes law. That agreement has to be reached by negotiation; that really is the only way forward. Some of the proposals in the legislation—such as the red and green routes—are sound and can be implemented. There is every indication that the European Union is willing to accept not all but at least some of those kinds of proposals, and I believe that that is the way forward. I do not believe that the Bill is the way forward and that is why, sadly, I shall not be supporting it tonight.